维普期刊资源整合服务平台（V6.5）

35篇 您的检索式：作者名="Kilhovd"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Increased serum levels of advanced glycation endproducts predict total,cardiovascular and coronary mortality in women with type 2 diabetes:a population-based 18 year follow-up study显示文摘	Kilhovd BK Juutilainen A Lehto S	2007	Diabetologia2007，50，7：	1
2	Increased serum levels of the specific advanced glycation end product methylglyoxal- derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus显示文摘	Fosmark DS Torjesen PA Kilhovd BK	2006	Metabolism2006，55，2：	1
3	Increased ser- um levels of advanced glycation endproducts predict total cardiovascular and coronary mortality in women with type 2 diabetes : a population-based 18 year follow-up study 显示文摘	Kilhovd BK Juutilainen A Lehto S	2007	Diabetologia2007，50，：	1
4	Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary hear disease显示文摘	Kilhovd BK Berg TJ Birkeland KI	2000	Diabetes Care2000，23，9：	1
5	superior glycemic control weth repaglinide compared with glipizide in type 2 diabetes 显示文摘	Madsbads kilhovd B Lager I	2000	Diabetes2000，49，1：	1
6	Increased serum levels of advanced glycation end products predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow up study显示文摘	Kilhovd B K Juutilainen A Lehto S	2007	Diabetologia2007，50，7：	1
7	Increased Serum levels of advanced glycation endproducts predict total cardio- vascular and cororuary mortality in women wity type 2 dia- betes : a population-based 18 year follow-up study 显示文摘	Kilhovd BK Juutilainen A Lehto S	2007	Dia- betologia2007，50，7：	1
8	Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia 显示文摘	Johansen OE Vanberg PJ Kilhovd BK	2009	Vasc Health Risk Manag2009，5，1：	1
9	Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary-heart disease显示文摘	Kilhovd BK Berg TJ Birkeland KI		0，，：	1
10	Tim course of specific AGEs during optimised glycaemic control in type 2 diabetes显示文摘	MENTINK C J KILHOVD B K RONDAS-COLBERS G J	2006	Neth J Med2006，64，1：	1
11	Repaglinide compared to glipizide in the treatment of type 2 diabetic patient显示文摘	DEJGAARD A MADSBAD S KILHOVD B	1998	Diadetologia1998，41，1：	1
12	Superior glycemic control with repaglinide compared with gl ipizide in type 2 diabetes显示文摘	Madsbad S Kilhovd B Lager I	2008	Diabetes2008，49，1：	1
13	Infarct size as estimated from pesk creatine kinase and lactale dehydrogenase is probably reduced in patients using calcium antagoists at the onset of symptoms显示文摘	Landmark K Abdelnoor M Kilhovd B		0，，04：	1
14	Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease 显示文摘	Kilhovd BK Berg TJ Birkeland KI	1999	Diabetes Care1999，22，9：	1
15	Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18?year follow-up study显示文摘	B. K. Kilhovd A. Juutilainen S. Lehto T. R?nnemaa P. A. Torjesen K. F. Hanssen M. Laakso	2007	Diabetologia2007，，7：	1
16	Formation of ad- vanced glycation end products (AGEs)may participate in the development of coronary heart disease in patients with type 2 diabetes 显示文摘	Kilhovd B Berg TJ Torjesen PA	1998	Diabetologia1998，41，1：	1
17	Serum levels of advanced glycation end products are increased in patients with type 2diabetes and coronary heart disease显示文摘	Kilhovd BK Berg TJ Bir Keland KI	1999	Diabetes Care1999，22，9：	1
18	Heterogeneity of non - insulin - dependent diabetes expressed as variability in insulin sensitivi- ty, beta - cell function and cardiovascular risk profile 显示文摘	Birkel and KI Kilhovd B Thorsby P	2003	Diabet Med2003，20，1：	1
19	In creased serum levels of ad- vanced glycation endproducts predict total cardiovascular and coror nary mortality in women with type 2 diabetes:a population-based 18 year fol- low-up study 显示文摘	Kilhovd BK Juutilainen A Lehto S	2007	Diabetologia2007，50，7：	1
20	Serum levels of advanced glycation end products are increased in patients with type I diabetes and coronary heart disease显示文摘	Kilhovd B K Herg T J Birkeland K I	1999	Diabetes Care1999，22，9：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示